SANUWAVE Health, Inc. (SNWV) Fair Value 2026

SNWV · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.4 /10

32 fundamental signals · 8 models active

Value Trap Risk

SAFE (24/100)

Quick Summary — As of 2026-08-27, SANUWAVE Health, Inc. (SNWV) trades at $4.66, versus a $6.94 median fair value across its 8 active models — 49.0% above the current price. QOC: 7.4/10. Value Trap Risk: 24/100 (SAFE). 8/13 models active. Within that set, the Bayesian DCF component alone returns $4.74.

Key Facts

Ticker
SNWV
Price
$4.66
Quality Score
7.4/10
Value Trap Risk
24/100
Models Active
8/13
Last Updated
Strength: First Chicago suggests +185.8% upside with 59% confidence
Risk: Limited model coverage (8/13) may reduce confidence

Is SANUWAVE Health, Inc. (SNWV) Undervalued or Overvalued in 2026?

According to CirclFi’s 8-model valuation engine, SANUWAVE Health, Inc. (SNWV) appears undervalued as of : the median of 8 independent fair value estimates is $6.94, 49.0% above the current price of $4.66. Estimates range from $2.84 to $13.32. SNWV scores 7.4/10 on fundamental quality and 24/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. SNWV’s +49.0% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy SANUWAVE Health, Inc. Stock in 2026? →

What Fair Value Does Each Model Give SNWV?

8 Intrinsic Value Models vs. Current Price ($4.66)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $4.74 +1.7%
Ensemble · Low Conviction
 $7.91 +69.7%
Scenario · High Conviction
 $13.32 +185.8%
Intrinsic · High Conviction
 $5.98 +28.3%
Unlock the Full Matrix

Access 4 additional models including EROIC Spread, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 8 Models →

Cancel anytime · No contracts · Instant access

What Is SNWV's Fair Value Range?

Spread across 8 independent models · $2.84 to $13.32

CirclFi's 8 active models place SANUWAVE Health, Inc. (SNWV) between $2.84 and $13.32 per share, a spread of 151% of the median. The median of that range — $6.94 — is the fair value CirclFi publishes for SNWV, against a current price of $4.66.

Low · EROICHigh · First Chicago
$2.84median $6.94$13.32
Where the range comes from
Most bearish modelEROIC Spread$2.84
Most bullish modelFirst Chicago$13.32
Model agreement5 bullish · 2 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for SNWV. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on SNWV, not a CirclFi price target. How each model works →

What Is SANUWAVE Health, Inc. (SNWV) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, SANUWAVE Health, Inc.'s intrinsic value is estimated at a median fair value of $6.94. While the stock appears modestly undervalued at $4.66 (implied upside of +49.0%), our analysis suggests a thinner margin of safety across 5 of 8 bullish models. Notably, First Chicago sees the most upside at +185.8% (fair value: $13.32), while EROIC is the most conservative at -39.0% ($2.84). The spread between these extremes — +224.8% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About SNWV?

8 of 13 models are currently active for SNWV. Of these, 6 models suggest upside while 2 models suggest overvaluation. Taken together, their median fair value for SNWV is $6.94 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $4.74 on its own, implying +1.7% upside from the current price. See which stocks rank higher →

How Does SNWV Rank in Medical Devices?

Among 157 Medical Devices stocks, SNWV ranks #36 by Quality of Company score. CirclFi's QOC score of 7.4/10 evaluates 32 fundamental signals. A score of 7.4 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to healthcare company businesses. For SANUWAVE Health, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is SNWV a Value Trap?

CirclFi's Value Trap algorithm assigns SNWV a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

8 of 13 models are active for SANUWAVE Health, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, SANUWAVE Health, Inc. scores 7.4 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +224.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SNWV valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SNWV's 8 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy SANUWAVE Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

DCTHDelcath Systems, Inc.QOC 7.4VREXVarex Imaging CorporationQOC 7.3SIBNSI-BONE, Inc.QOC 7.5SRTSSensus Healthcare, Inc.QOC 7.3BRKRBruker CorporationQOC 7.5SGHTSight Sciences, Inc.QOC 7.3ECORelectroCore, Inc.QOC 6.4QSIQuantum-Si incorporatedQOC 5.4WOKWORK Medical Technology Group LTDQOC 2.8IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: DCTH · VREX · SIBN · SRTS · BRKR · SGHT · ECOR · QSI · WOK · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to SNWV?

7 companies across all industries closest to SNWV’s Quality of Company score of 7.4/10.

SHLSShoals Technologies Group, Inc.QOC 7.4NTRNutrien Ltd.QOC 7.4GTIMGood Times Restaurants Inc.QOC 7.4LYGLloyds Banking Group plcQOC 7.4PIImpinj, Inc.QOC 7.4PEGPublic Service Enterprise Group IncorporatedQOC 7.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SHLS · NTR · GTIM · LYG · PI · PEG · NVDA

Where Does SNWV Sit in CirclFi's Medical Devices Rankings?

SNWV is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About SANUWAVE Health, Inc.’s Valuation?

What is SANUWAVE Health, Inc.'s intrinsic value in 2026?

CirclFi puts SANUWAVE Health, Inc. (SNWV)'s intrinsic value at $6.94 — the median of 8 independent model estimates as of 2026-08-27, ranging from $2.84 to $13.32. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $4.74 on its own. The Quality of Company score is 7.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SNWV overvalued or undervalued right now?

At $4.66, 6 of 8 active models suggest SNWV may be undervalued, while 2 indicate potential overvaluation. The median of all 8 fair value estimates is $6.94, 49.0% above the current price of $4.66 — a consensus view that SNWV is undervalued. The assessment depends on which methodology best fits SANUWAVE Health, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 7.4 mean for SNWV?

SANUWAVE Health, Inc.'s QOC of 7.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SNWV?

CirclFi analyzes SNWV with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 8 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on SNWV?

Of the 8 models currently active on SNWV, First Chicago is the most bullish at $13.32 per share, and EROIC Spread is the most bearish at $2.84. CirclFi's published fair value for SNWV is the median of that range, $6.94, not either extreme. The gap between the two ends equals 151% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is SNWV a value trap in 2026?

SANUWAVE Health, Inc.'s Value Trap score is 24/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 8-model valuation engine, SANUWAVE Health, Inc. (SNWV) has a median fair value of $6.94 — 49.0% above the current price of $4.66 — as of 2026-08-27.” Source: circlfi.com/stock/SNWV/ · Methodology
Primary sources for this SNWV valuation
  • Financial statements: SANUWAVE Health, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001417663) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SNWV as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 8 mathematical frameworks give you clarity on SNWV.

Unlock All 8 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

4 models hidden for SNWV Unlock All 8 — $39/mo